Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials

Antipsychotic-induced dyslipidemia could increase the risk of cardiovascular diseases. This is a meta-analysis of randomized double-blind placebo-controlled trials to examine the efficacy and safety of adjunctive metformin for dyslipidemia induced by antipsychotics in schizophrenia. The standardized...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Wen-Long, Cai, Dong-Bin, Yin, Fei, Zhang, Ling, Zhao, Xi-Wu, He, Jie, Ng, Chee H., Ungvari, Gabor S., Sim, Kang, Hu, Mei-Ling, Zheng, Wei, Xiang, Yu-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181777/
https://www.ncbi.nlm.nih.gov/pubmed/32327628
http://dx.doi.org/10.1038/s41398-020-0785-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181777/
https://www.ncbi.nlm.nih.gov/pubmed/32327628
http://dx.doi.org/10.1038/s41398-020-0785-y

Ejemplares similares